Lysophosphatidic acid stimulates prostaglandin E2 production in cultured stromal endometrial cells through LPA1 receptor

Experimental Biology and Medicine

Volumn 234, Issue 8, 2009, Pages 986-993

  Woclawek Potocka, Izabela ^a   Kondraciuk, Katarzyna ^a   Skarzynski, Dariusz Jan ^a  

^a INSTITUTE OF ANIMAL REPRODUCTION AND FOOD RESEARCH   (Poland)

Author keywords

Cow; Lysophosphatidic acid; Prostaglandins; Uterus

Indexed keywords

3 [4 [4 [[1 (2 CHLOROPHENYL)ETHOXY]CARBONYLAMINO] 3 METHYL 5 ISOXAZOLYL]BENZYLTHIO]PROPANOIC ACID; DIACYLGLYCEROL PYROPHOSPHATE; KI 16425; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID 1; LYSOPHOSPHATIDIC ACID RECEPTOR; N ACYLETHANOLAMIDE PHOSPHATE; OXYTOCIN; PROSTAGLANDIN E2; PROTEIN INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; ENDOMETRIUM CELL; EPITHELIUM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROSTAGLANDIN RELEASE; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CALCIUM SIGNALING; CATTLE; CELL SURVIVAL; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROST; DINOPROSTONE; DIPHOSPHATES; ENDOMETRIUM; EPITHELIAL CELLS; FEMALE; GLYCEROL; INTRACELLULAR SPACE; INTRAMOLECULAR OXIDOREDUCTASES; ISOXAZOLES; LYSOPHOSPHOLIPIDS; PROPIONIC ACIDS; RECEPTORS, LYSOPHOSPHATIDIC ACID; RNA, MESSENGER; STROMAL CELLS;

BOVINAE;

EID: 68149131445     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0901-RM-36     Document Type: Article

References (36)

1. Asselin E, Drolet P, Fortier MA. Cellular mechanisms involved during oxytocin-induced prostaglandin F2alpha production in endometrial epithelial cells in vitro: Role of cyclooxygenase-2. Endocrinology 138:4798-4805, 1997.
2. 2α in the bovine endometrium. J Biol Chem 278:11205-11212, 2003.
3. Danet-Desnoyers G, Meyer MD, Gross TS, Johnson JW, Thatcher WW. Regulation of endometrial prostaglandin synthesis during early pregnancy in cattle: Effects of phospholipases and calcium in vitro. Prostaglandins 50:313-321, 1995.
4. 2α release at luteolysis in cattle? Biol Reprod 62:1109-1115, 2000.
5. 2 and response to oxytocin in cultured epithelial and stromal cells of the bovine endometrium. Biol Reprod 54:371-379, 1996.
6. Kotwica J, Skarzynski D, Mlynarczuk J, Rekawiecki R. Role of prostaglandin E2 in basal and noradrenaline-induced progesterone secretion by the bovine corpus luteum. Prostaglandins Other Lipid Mediat 70:351-359, 2003.
7. Magness RR, Huie JM, Hoyer GL, Huecksteadt TP, Reynolds LP, Seperich GJ, Whysong G, Weems CW. Effect of chronic ipsilateral or contralateral intrauterine infusion of prostaglandin E2 (PGE2) on luteal function of unilaterally ovariectomized ewes. Prostaglandins Med 6:389-401, 1981.
8. Reynolds LP, Stigler J, Hoyer GL, Magness RR, Huie JM, Huecksteadt TP, Whysong GL, Behrman HR, Weems CW. Effect of PGE1 on PGF2 induced luteolysis in nonbred ewes. Prostaglandins 21:957-972, 1981.
9. Emond V, Fortier MA, Murphy BD, Lambert RD. Prostaglandin E2 regulates both interleukin-2 and granulocyte-macrophage colonystimulating factor gene expression in bovine lymphocytes. Biol Reprod 58:143-151, 1998.
10. Ye X, Hama K, Contos JA, Suzuki H, Amano T, Arai H, Aoki J, Chun J. LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature 435:104-108, 2005.
11. Seo H, Kim M, Choi Y, Lee CK, Ka H. Analysis of lysophosphatidic acid (LPA) receptor and LPA-induced endometrial prostaglandinendoperoxide synthase 2 expression in the porcine uterus. Endocrinology 149:6166-6175, 2008.
12. Liszewska E, Reinaud P, Billon-Denis E, Dubois O, Robin P, Charpigny G. Lysophosphatidic acid signaling during embryo development in sheep: Involvement in prostaglandin synthesis. Endocrinology 150:422-434, 2009.
13. Woclawek-Potocka I, Komiyama J, Saulnier-Blache JS, Brzezicka E, Bah MM, Okuda K, Skarzynski DJ. Lysophosphatic acid modulates prostaglandin secretion in the bovine uterus. Reproduction 137:95-105, 2009.
14. Bandoh M, Aoki J, Hosono H, Kobayashii S, Murakami-Murofushii K, Arai H, Inoue K. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J Biol Chem 274:27776-27785, 1999.
15. Im DS, Heise C, Harding M, George S, Theodorescu D, Lynch K. Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate. Mol Pharmacol 57:753-759, 2000.
16. Noguchi K, Ishii S, Shimizu T. Identification of p2y9/GPR23 as a novel G protein- coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J Biol Chem 278:25600-25606, 2003.
17. Ohta H, Sato K, Murata N, Damirin A, Malchinkhuu E, Kon J, Kimura T, Tobo M, Yamazaki Y, Watanabe T, Yagi M, Sato M, Suzuki R, Murooka H, Sakai T, Nishitoba T, Im DS, Nochi H, Tamoto K, Tomura H, Okajima F. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors. Mol Pharmacol 64:994-1005, 2003.
18. Fischer DJ, Nusser N, Virag T, Yokoyama K, Wang DA, Baker DL, Bautista D, Parrill AL, Tigyi G. Naturally occuring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes. Mol Pharmacol 60:776-784, 2001.
19. Durgam GG, Tsukahara R, Makarova N. Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligands. Bioorg Med Chem Lett 16:633-640, 2006.
20. Kaminska K, Wasielak M, Bogacka I, Blitek M, Bogacki M. Quantitative expression of lysophosphatidic acid receptor 3 gene in porcine endometrium during the periimplantation period and estrous cycle. Prostaglandins Other Lipid Mediat 85:26-32, 2008.
21. Skarzynski DJ, Siemieniuch MJ, Pilawski W, Woclawek Potocka I, Bah MM, Majewska M, Jaroszewski JJ. In vitro assessment of progesterone and prostaglandin E(2) production by the corpus luteum in cattle following pharmacological synchronization of estrus. J Reprod Dev 29:170-176, 2009.
22. Murakami S, Shibaya M, Takeuchi K, Skarzynski DJ, Okuda K. A passage and storage system for isolated bovine endometrial epithelial and stromal cells. J Reprod Dev 49:531-538, 2003.
23. 2α by cultured bovine endometrial cells in response to tumor necrosis factor-α: Cell type specificity and intracellular mechanisms. Biol Reprod 62:1116-1120, 2000.
24. Woclawek-Potocka I, Acosta TJ, Korzekwa A, Bah MM, Shibaya M, Okuda K, Skarzynski DJ. Phytoestrogens modulate prostaglandin production in bovine endometrium: Cell type specificity and intracellular mechanisms. Exp Biol Med 230:326-333, 2005.
25. Woclawek-Potocka I, Borkowski K, Korzekwa A, Okuda K, Skarżyński DJ. Phyto- and endogenous estrogens differently activate intracellular calcium ion mobilization in the bovine endometrial cells. J Reprod Dev 52:731-740, 2006.
26. Shemesh M, Hansel W. Stimulation of prostaglandin synthesis in bovine ovarian tissues by arachidonic acid and luteinizing hormone. Biol Reprod 13:448-452, 1975.
27. Palliser HK, Hirst JJ, Ooi GT, Rice GE, Dellios NL, Escalona RM, Parkington HC, Young IR. Prostaglandin e and f receptor expression and myometrial sensitivity at labor onset in the sheep. Biol Reprod 72:937-943, 2005.
28. Franczak A, Kotwica G, Kurowicka B, Oponowicz A, Wocławek-Potocka I, Petroff BK. Expression of enzymes of cyclooxygenase pathway and secretion of prostaglandin E2 and F2alpha by porcine myometrium during luteolysis and early pregnancy. Theriogenology 66:1049-1056, 2006.
29. Arnould T, Thibaut-Vercruyssen R, Bouaziz N, Dieu M, Remacle J, Michiels C. PGF(2alpha), a prostanoid released by endothelial cells activated by hypoxia, is a chemoattractant candidate for neutrophil recruitment. Am J Pathol 159:345-357, 2001.
30. Asselin E, Fortier MA. Detection and regulation of the messenger for a putative bovine endometrial 9-keto-prostaglandin E(2) reductase: Effect of oxytocin and interferon-tau. Biol Reprod 62:125-131, 2000.
31. Contos J, Ishii I, Chun J, Ye X. Characterization of LPA2 (edg4) and LPA1/LPA2 (edg2 and edg4) lysophosphatidic acid receptor knockout mice: Signaling deficits without obvious phenotypic abnormality attributable to LPA2. Mol Cell Biol 22:6921-6929, 2002.
32. Gardell S, Dubin A, Chun J. Emerging medical roles for lysophospolipid signaling. Trends Mol Med 12:65-75, 2006.
33. Inoue CN, Forster HG, Epstein M. Effects of lysophosphatidic acid, a novel lipid mediator, on cytosolic Ca2+ and contractility in cultured rat mesangial cells. Circ Res 77:888-896, 1995.
34. Reiser CO, Lanz T, Hofmann F, Hofer G, Rupprecht HD, Goppelt-Struebe M. Lysophosphatidic acid-mediated signal-transduction pathways involved in the induction of the early-response genes prostaglandin G/H synthase-2 and Egr-1: A critical role for the mitogenactivated protein kinase p38 and for Rho proteins. Biochem J 330:1107-1114, 1998.
35. Synowicz J, Adley BP, Woo MM, Auersperg N, Hudson LG, Stack MS. Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells. Cancer Res 65:2234-2242, 2005.
36. D'Aquilio F, Procaccini M, Izzi V, Chiurchiu V, Giambra V, Carotenuto F, Di Nardo P, Baldini PM. Activatory properties of lysophosphatidic acid on human THP-1 cells. Inflammation 30:167-177, 2007.